PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients

PURPOSE: Mutations in the PIK3CA gene occur frequently in breast cancer patients. Activating PIK3CA mutations confer resistance to human epidermal growth factor receptor 2 (HER2)–targeted treatments. In this study, we investigated whether PIK3CA mutations were correlated with treatment response or d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju Won, Lim, Ah Reum, You, Ji Young, Lee, Jung Hyun, Song, Sung Eun, Lee, Nam Kwon, Jung, Seung Pil, Cho, Kyu Ran, Kim, Cheol Yong, Park, Kyong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101795/
https://www.ncbi.nlm.nih.gov/pubmed/36097803
http://dx.doi.org/10.4143/crt.2022.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101795/
https://www.ncbi.nlm.nih.gov/pubmed/36097803
http://dx.doi.org/10.4143/crt.2022.221

Ejemplares similares